4:43 PM ET
8-K
Loan & Debt
Vaxcyte $575M Debt Financing with U.S. Bank Trust Company, National Association
Vaxcyte, Inc. completed the sale and issuance of $575 million in 1.50% Convertible Senior Notes due 2032. The notes are senior unsecured obligations with an initial conversion price of approximately $89.60 per share of common stock. The company intends to use the proceeds for general corporate purposes, which may include research and development and working capital.
- Value
- $575M
- Counterparty
- U.S. Bank Trust Company, National Association
- Term
- through Oct 2032